Latest On-Demand Webinars

Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.

Speaking at The Landscape of Cancer Research 2022, Osama Al Dalahmah, PhD from Colombia University, presented his talk on paving the way to new mechanistic and therapeutic discoveries in glioblastoma.

Multiplex assays combine several target analytes in a single reaction volume, allowing multiple biomarkers to be measured simultaneously.

The best fluids for mining disease biomarkers are closest to the site of pathology. For example, rather than serum or plasma, urine is a better fluid to in patients with urinary tract diseases, and stool may be a preferred material to examine in a subject with gastrointestinal disease.

In bioprocessing, it is critical that host cell proteins (HCPs) can be identified, detected and removed so that the efficacy of the drug is not impacted, and custom process-specific HCP ELISA are typically the preferred method for measuring these contaminants.

Join us for our extended webinar to hear about the most recent and innovative developments in the world of mass spectrometry and how they are helping to drive science forward.

The administration of drugs via inhalation into the lungs is superior to many other methods of delivery because our lungs provide a large surface area for absorption, access to the whole blood volume and comparatively little metabolic activity. Currently, there are limited in vitro models in which the absorption and permeability of drugs across the lung and into systemic circulation can be precisely measured.

In this webinar, Dr. Emily Richardson will describe novel lung-on-a-chip (LOAC), otherwise known as lung microphysiolological system, models of the alveoli and bronchi which can be used to accurately predict drug pharmacokinetics, allowing for more rapid, precise and cost-effective analysis of compounds.

In this webinar, we will explore the applications for high-resolution ion mobility (HRIM) mass spec based on structures for lossless ion manipulation (SLIM) in biopharmaceutical applications. Topics will cover intact mass analysis, peptide mapping and post-translational modification identification and future applications for the technology in the biopharmaceutical space.

There is currently significant demand for the development of new and improved analytical methods for the characterization of mRNA therapeutics.

Join us on June 22 with Boris Heifets, MD, PhD, Assistant Professor of the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine, who will explore the future of psychedelic medicine.